Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $9.6 million.

  • Rockwell Medical's Total Current Liabilities fell 3241.64% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 3241.64%. This contributed to the annual value of $14.1 million for FY2024, which is 1530.32% down from last year.
  • Latest data reveals that Rockwell Medical reported Total Current Liabilities of $9.6 million as of Q3 2025, which was down 3241.64% from $10.9 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Total Current Liabilities registered a high of $34.0 million during Q2 2021, and its lowest value of $9.6 million during Q3 2025.
  • For the 5-year period, Rockwell Medical's Total Current Liabilities averaged around $17.0 million, with its median value being $16.6 million (2023).
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 19611.01% in 2021, then tumbled by 4554.62% in 2022.
  • Over the past 5 years, Rockwell Medical's Total Current Liabilities (Quarter) stood at $21.0 million in 2021, then decreased by 15.62% to $17.7 million in 2022, then fell by 5.96% to $16.6 million in 2023, then fell by 15.3% to $14.1 million in 2024, then tumbled by 32.0% to $9.6 million in 2025.
  • Its last three reported values are $9.6 million in Q3 2025, $10.9 million for Q2 2025, and $11.2 million during Q1 2025.